Abstract
Societal responses crucially shape the course of a pandemics but are difficult to predict. Mitigation dynamics is introduced here as an integral part of an epidemiological model, which is applied to the ongoing SARS-CoV-2 pandemic. Unperturbed simulations accurately reproduce diverse epidemic and social response trajectories from 2020 to 2021 reported from 11 European countries, Iran, and 8 US states. High regional variability in the severity and duration of the spring lockdown and in peak mortality rates of the first SARS-CoV-2 wave can be explained by differences in mitigation readiness H which is here mathematically defined as the value of human lives in relation to business-as-usual contact rates. H entails a suite of political, social, and psychological aspects of decision making. The simulations also suggest that a subsequent decrease in H much intensified the second wave and slowed down its decay. With less effective lockdowns, vaccination became the primary mitigation strategy in 2021. Retardation of vaccination relative to a 3-month scheme is projected to provoke an average toll of 1.5 deaths per million and delayed day. This toll particularly rises in regions with high numbers of old and still susceptible people, which is relevant for revising current policies of vaccine distribution.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author is funded by the Helmholtz Association.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n.a.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All used observation were downloaded from publically available sources. The code required to produce all model results is available at https://github.com/kaiwirtz/CovidSocMod